Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › KY › MORGANFIELD › DEACONESS UNION COUNTY HOSPITAL, INC

DEACONESS UNION COUNTY HOSPITAL, INC

NPI: 1497320519 · MORGANFIELD, KY 42437 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 05/21/2021

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WATHEN, CHERYL controls 20+ related entities in our dataset. Read more

$10.10M
Total Medicaid Paid
158,330
Total Claims
108,135
Beneficiaries
112
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWATHEN, CHERYL (CFO)
NPI Enumeration Date05/21/2021

Related Entities

Other providers sharing the same authorized official: WATHEN, CHERYL

ProviderCityStateTotal Paid
DEACONESS CLINIC, INC NEWBURGH IN $6.54M
DEACONESS HOSPITAL, INC EVANSVILLE IN $5.62M
DEACONESS HOSPITAL, INC NEWBURGH IN $3.36M
DEACONESS HOSPITAL, INC EVANSVILLE IN $3.30M
DEACONESS CLINIC, INC EVANSVILLE IN $3.09M
DEACONESS HOSPITAL, INC. EVANSVILLE IN $2.52M
DEACONESS CLINIC, INC NEWBURGH IN $2.09M
DEACONESS HOSPITAL, INC EVANSVILLE IN $2.06M
DEACONESS HOSPITAL, INC EVANSVILLE IN $1.56M
DEACONESS CLINIC, INC EVANSVILLE IN $1.56M
DEACONESS CLINIC, INC. PRINCETON IN $1.55M
DEACONESS CLINIC INC. EVANSVILLE IN $1.32M
DEACONESS HOSPITAL, INC NEWBURGH IN $1.27M
DEACONESS CLINIC INC EVANSVILLE IN $1.15M
DEACONESS CLINIC, INC BOONVILLE IN $1.15M
DEACONESS CLINIC INC OWENSBORO KY $957K
DEACONESS CLINIC, INC HENDERSON KY $911K
DEACONESS SPECIALTY PHYSICIANS, INC EVANSVILLE IN $885K
DEACONESS CLINIC, INC PETERSBURG IN $872K
DEACONESS CLINIC INC. EVANSVILLE IN $828K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 27,753 $1.14M
2019 26,398 $997K
2020 13,285 $545K
2021 8,056 $571K
2022 32,548 $2.30M
2023 28,166 $2.51M
2024 22,124 $2.04M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 5,779 4,504 $2.27M
99283 Emergency department visit for the evaluation and management, moderate severity 12,174 10,092 $2.02M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,289 1,364 $848K
74177 Computed tomography, abdomen and pelvis; with contrast material 612 540 $684K
70450 Computed tomography, head or brain; without contrast material 1,107 898 $360K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,834 2,421 $340K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7,617 1,630 $330K
74176 Computed tomography, abdomen and pelvis; without contrast material 401 352 $312K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,987 2,367 $203K
80053 Comprehensive metabolic panel 13,224 8,923 $184K
71045 Radiologic examination, chest; single view 2,188 1,811 $161K
36415 Collection of venous blood by venipuncture 21,898 9,430 $128K
71046 Radiologic examination, chest; 2 views 2,204 1,765 $127K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,315 640 $121K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 11,452 8,532 $119K
80050 General health panel 2,070 1,565 $111K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,284 1,347 $110K
G0378 Hospital observation service, per hour 872 425 $100K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,309 1,022 $88K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,680 1,365 $87K
96361 Intravenous infusion, hydration; each additional hour 868 520 $76K
84484 2,656 1,925 $75K
99282 Emergency department visit for the evaluation and management, low to moderate severity 776 674 $67K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,116 960 $66K
80061 Lipid panel 1,904 1,722 $51K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 592 463 $51K
81001 5,240 4,349 $51K
83735 3,404 2,631 $50K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,268 394 $49K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,620 1,432 $49K
84443 Thyroid stimulating hormone (TSH) 2,158 1,929 $45K
83690 2,213 1,823 $39K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 893 795 $39K
96375 Therapeutic injection; each additional sequential IV push 567 424 $37K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 497 198 $34K
87040 597 475 $33K
84439 2,264 2,019 $32K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 720 604 $31K
82607 746 664 $28K
83605 915 739 $25K
80048 Basic metabolic panel (calcium, ionized) 2,525 1,787 $23K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 290 254 $22K
87086 Culture, bacterial; quantitative colony count, urine 1,448 1,138 $22K
83874 1,102 751 $21K
82550 1,438 1,040 $19K
73630 164 132 $17K
83036 Hemoglobin; glycosylated (A1C) 1,081 980 $17K
84703 837 752 $15K
82553 935 661 $15K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 263 187 $15K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,196 1,717 $14K
81025 860 734 $13K
87430 750 672 $13K
97014 425 134 $13K
77067 Screening mammography, bilateral, including computer-aided detection 120 110 $13K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 676 174 $12K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,018 698 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 737 333 $10K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 451 382 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 163 129 $10K
87081 314 254 $10K
83540 508 472 $9K
82150 769 633 $9K
96376 152 88 $9K
73610 73 63 $8K
82728 231 208 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 270 239 $7K
87077 1,114 614 $7K
83550 305 285 $7K
87186 634 424 $7K
86803 164 139 $6K
85379 223 198 $6K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 74 70 $6K
76705 Ultrasound, abdominal, real time with image documentation; limited 26 24 $5K
94760 299 177 $5K
97162 48 42 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,153 876 $4K
82947 312 149 $4K
85610 433 346 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,174 1,670 $3K
77063 Screening digital breast tomosynthesis, bilateral 167 141 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 225 185 $3K
81015 510 449 $3K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 50 12 $3K
85652 302 269 $2K
81003 432 359 $2K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 160 134 $2K
74022 16 14 $2K
82746 38 38 $2K
82077 96 71 $2K
86140 133 99 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 103 97 $2K
82043 84 65 $2K
97161 13 13 $2K
73030 20 12 $2K
80076 63 47 $1K
73130 18 13 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg 67 38 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 14 12 $963.61
82248 151 139 $946.49
J2270 Injection, morphine sulfate, up to 10 mg 275 189 $906.05
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 14 14 $896.40
J3490 Unclassified drugs 14 12 $821.38
87420 17 16 $533.31
85027 53 39 $497.99
83880 20 14 $425.79
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 37 34 $292.63
85007 34 26 $191.10
87070 13 12 $183.90
J2550 Injection, promethazine hcl, up to 50 mg 98 77 $130.80
J2704 Injection, propofol, 10 mg 13 12 $76.40
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 15 14 $7.96